Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs iShares MSCI United Kingdom (FTSE) (EWU) Price & Performance

Amylx Pharmaceuticals IncTrade
iShares MSCI United Kingdom (FTSE)Trade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs iShares MSCI United Kingdom (FTSE) — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while iShares MSCI United Kingdom (FTSE) trades at $48.28. Which is the better fit depends on your goals.

AMLXEWU
Market Cap
$2.64B
Sector
HealthBroad Market / Factor
52-Week High
$24.19$48.68
52-Week Low
$7.82$40.90
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About iShares MSCI United Kingdom (FTSE)

EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.

Read more on EWU